OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
KSRM54

Kesoram Industries Ltd

Specialty ChemicalsVerified

Kesoram Industries has a debt-to-equity ratio of 0.44 and a current ratio of 0.68, indicating a moderate liquidity position with current liabilities exceeding current assets. The company reported negative operating income of INR 837.9 million, but a net income of INR 55,651.6 million, which is largely attributed to non-operating gains or one-time items. The return on equity (ROE) is 12.32%, and return on assets (ROA) is 6.85%, both of which are above the industry median for Specialty Chemicals, suggesting strong capital efficiency. The company's profitability is driven by its rayon and transparent paper segments, which are its primary revenue contributors. The rayon segment is the largest, with the company producing deniers ranging from 75 to 700. The transparent paper segment is also a significant contributor, though the exact revenue share is not disclosed. The chemicals and others segment is a smaller contributor to the company's overall revenue. Kesoram Industries reported revenue of INR 2,587.6 million in the latest period, with a gross profit of INR 719.5 million. The company's operating cash flow is INR 373.4 million, but its free cash flow is negative at INR 843.9 million, indicating that capital expenditures are outpacing operating cash flow. The company's capital expenditure for the period was INR 60.4 million, which is relatively low compared to its operating cash flow. The company's growth trajectory is mixed. While the latest actual revenue of INR 38,919.6 million is significantly higher than the reported revenue of INR 2,587.6 million, this discrepancy may be due to the timing of the financial reporting periods or the inclusion of non-operating revenue in the analyst estimate. The company's operating income is negative, which could signal challenges in maintaining profitability in the near term. Kesoram Industries faces a medium liquidity risk, as indicated by its current ratio of 0.68 and a negative net cash position after subtracting total debt. The company's dilution risk is low, with no significant dilution sources identified in the latest filings. However, the company's free cash flow is negative, which could lead to increased reliance on external financing in the future. Recent events include the company's reported net income of INR 55,651.6 million, which is significantly higher than its operating income of INR 837.9 million. This suggests that the company may have realized substantial non-operating gains or had one-time items that positively impacted its net income. The company's operating cash flow is positive, but its free cash flow is negative, indicating that capital expenditures are outpacing operating cash flow.

30-day price · KSRM+3.98 (+47.8%)
Low$7.97High$14.26Close$12.30As of17 May, 00:00 UTC
Profile
CompanyKesoram Industries Ltd
TickerKSRM.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Kesoram Industries has a debt-to-equity ratio of 0.44 and a current ratio of 0.68, indicating a moderate liquidity position with current liabilities exceeding current assets. The company reported negative operating income of INR 837.9 million, but a net income of INR 55,651.6 million, which is largely attributed to non-operating gains or one-time items. The return on equity (ROE) is 12.32%, and return on assets (ROA) is 6.85%, both of which are above the industry median for Specialty Chemicals, suggesting strong capital efficiency. The company's profitability is driven by its rayon and transparent paper segments, which are its primary revenue contributors. The rayon segment is the largest, with the company producing deniers ranging from 75 to 700. The transparent paper segment is also a significant contributor, though the exact revenue share is not disclosed. The chemicals and others segment is a smaller contributor to the company's overall revenue. Kesoram Industries reported revenue of INR 2,587.6 million in the latest period, with a gross profit of INR 719.5 million. The company's operating cash flow is INR 373.4 million, but its free cash flow is negative at INR 843.9 million, indicating that capital expenditures are outpacing operating cash flow. The company's capital expenditure for the period was INR 60.4 million, which is relatively low compared to its operating cash flow. The company's growth trajectory is mixed. While the latest actual revenue of INR 38,919.6 million is significantly higher than the reported revenue of INR 2,587.6 million, this discrepancy may be due to the timing of the financial reporting periods or the inclusion of non-operating revenue in the analyst estimate. The company's operating income is negative, which could signal challenges in maintaining profitability in the near term. Kesoram Industries faces a medium liquidity risk, as indicated by its current ratio of 0.68 and a negative net cash position after subtracting total debt. The company's dilution risk is low, with no significant dilution sources identified in the latest filings. However, the company's free cash flow is negative, which could lead to increased reliance on external financing in the future. Recent events include the company's reported net income of INR 55,651.6 million, which is significantly higher than its operating income of INR 837.9 million. This suggests that the company may have realized substantial non-operating gains or had one-time items that positively impacted its net income. The company's operating cash flow is positive, but its free cash flow is negative, indicating that capital expenditures are outpacing operating cash flow.
Key takeaways
  • Kesoram Industries has a strong return on equity (12.32%) and return on assets (6.85%), indicating efficient use of capital.
  • The company's liquidity position is moderate, with a current ratio of 0.68 and a negative net cash position after subtracting total debt.
  • The company's profitability is driven by its rayon and transparent paper segments, with the rayon segment being the largest contributor.
  • The company's free cash flow is negative, indicating that capital expenditures are outpacing operating cash flow.
  • The company's net income is significantly higher than its operating income, suggesting the presence of non-operating gains or one-time items.
  • --
  • **RATIONALES**:
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$2.59B
Gross profit$719.5M
Operating income-$837.9M
Net income$55.65B
R&D
SG&A
D&A
SBC
Operating cash flow$373.4M
CapEx-$60.4M
Free cash flow-$843.9M
Total assets$8.13B
Total liabilities$3.61B
Total equity$4.52B
Cash & equivalents
Long-term debt$1.99B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$4.52B
Net cash-$1.99B
Current ratio0.7
Debt/Equity0.4
ROA6.8%
ROE12.3%
Cash conversion1.0%
CapEx/Revenue-2.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricKSRMActivity
Op margin-32.4%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin2150.7%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin27.8%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-2.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity44.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual revenue38,919,600,000 INR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 23:14 UTC#7ec7d124
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 12:10 UTCJob: 956e4f75